# Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery

> **NCT00727441** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 87 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** GVAX pancreatic cancer vaccine
- **DRUG:** cyclophosphamide

## Key facts

- **NCT ID:** NCT00727441
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-02
- **Primary completion:** 2015-05
- **Final completion:** 2019-02
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2020-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00727441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00727441, "Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT00727441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*